Serum Interleukin Levels and Insulin Resistance in Major Depressive Disorder

E-ISSN： 1996-3181|17|8|618-625

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.17, Iss.8, 2018-10, pp. : 618-625

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Serum Interleukin 2 Levels in Patients with Rheumatoid Arthritis and Correlation with Insulin Sensitivity

By Öncül O Top C Özkan S Çavuşlu Ş Danaci M

The Journal of International Medical Research, Vol. 30, Iss. 4, 2002-07 ,pp. : 386-390

Field House Publishing

Access to resources Recommend Favorite

Vilazodone: In Major Depressive Disorder

By Frampton James E.

CNS Drugs, Vol. 25, Iss. 7, 2011-07 ,pp. : 615-627

Adis International

Access to resources Recommend Favorite

Aripiprazole: In Major Depressive Disorder

By Weber Juliane Lyseng-Williamson Katherine A. Scott Lesley J.

CNS Drugs, Vol. 22, Iss. 10, 2008-01 ,pp. : 807-813

Adis International

Access to resources Recommend Favorite

Agomelatine for the treatment of major depressive disorder

By Carney Regina M Shelton Richard C

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 15, 2011-10 ,pp. : 2411-2419

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs for major depressive disorder

By Kennedy Sidney H Rizvi Sakina J

Expert Opinion on Emerging Drugs, Vol. 14, Iss. 3, 2009-09 ,pp. : 439-453

Informa Healthcare

Access to resources Recommend Favorite